EAGLE PHARMACEUTICALS, INC.

Eagle Pharmaceuticals, Inc. specializes in the manufacturing of specialized pharmaceutical preparations, with a primary focus on medicinal and botanical products for critical care applications. The company’s technical expertise centers on the development and production of injectable therapeutics, particularly high-potency agents such as dantrolene sodium, used to treat life-threatening conditions like malignant hyperthermia. Their manufacturing processes adhere to strict cGMP standards, ensuring consistent quality and regulatory compliance for mission-critical medical products. A key differentiator is their ability to deliver complex, low-volume specialty drugs with rapid turnaround, supporting urgent operational needs in defense and veteran healthcare settings. The contractor maintains a consistent and primary relationship with the Department of Defense, supplying essential pharmaceuticals to military medical supply chains, including battlefield-ready formulations and emergency response therapeutics. They also serve the Department of Veterans Affairs with specialized drug products tailored to veteran health needs, particularly in anesthesia and neuromuscular care. These engagements reflect a trusted, recurring partnership built on reliability, regulatory precision, and timely delivery of controlled substances under federal procurement frameworks. Eagle Pharmaceuticals operates primarily within NAICS 325411 (Medicinal and Botanical Manufacturing), indicating a focused vertical in the production of active pharmaceutical ingredients and finished dosage forms derived from botanical or synthetic sources. Their market positioning is that of a niche supplier of high-acuity, low-volume injectables, serving specialized segments where regulatory rigor and supply chain continuity are paramount. They also engage in wholesale distribution of medical sundries under NAICS 424210, supporting end-to-end pharmaceutical logistics. As a 2L entity headquartered in Woodcliff Lake, New Jersey, Eagle Pharmaceuticals is a mid-sized manufacturer without federal certifications such as 8(a), HUBZone, or WOSB. Their geographic presence is centralized, with operations aligned to support federal procurement requirements through FDA-registered facilities and compliant manufacturing infrastructure.